Studies on the pharmacokinetics and metabolism of N4-carbamoyl-1,3,4,5-dihydro-diazepam (Uxepam®) in rats, dogs and man
✍ Scribed by M. Vajda; Zs. Tegyey; M. Kozma; L. Vereczkey
- Publisher
- Elsevier Science
- Year
- 1986
- Tongue
- English
- Weight
- 461 KB
- Volume
- 4
- Category
- Article
- ISSN
- 0731-7085
No coin nor oath required. For personal study only.
✦ Synopsis
The pharmacokinetics and metabolism of Uxepams', a new minor tranquillizer, have been investigated in rats [2], dogs and man. For the experiments in rats [2] separation of metabolites of 2-14C-uxepam was achieved by thin-layer chromatography.
In the experiments on dogs and man, Extrelut microcolumns were used for preseparation. Recovery was 95% f 12.77 (S.D.) determined by radioactive tracer experiments. The compounds were separated and determined by reversed-phase HPLC with UV detection at 240 nm. The limit of detection for uxepam was 10 ng ml-'. The metabolites were identified by mass spectrometry.
The main metabolites in the rat were desmethyl-uxepam, 5-hydroxy-phenyl-desmethyl-uxepam and diazepam. Desmethyl-carbamoyl-dihydro-diazepam, diazepam and desmethyl-diazepam were found in human plasma. In dogs only one metabolite, desmethyl-uxepam, was detected in plasma. Enterohepatic recycling was observed in dogs and in humans.
📜 SIMILAR VOLUMES
This study was conducted to provide data on the pharmacokinetics of [ 14 C]metosulam (N-[2,6-dichloro-3-methylphenyl]-5,7-dimethoxy-1,2,4-triazolo-[1,5a]-[pyrimidine-2-sulfonamide). Groups of male Sprague-Dawley rats, CD-1 mice and Beagle dogs were given a single oral gavage dose of 100 mg [ 14 C]me
## Abstract The interaction of 4‐amino‐4H,3,5‐di(methoxy)‐1,2,4‐triazole (ATD), (4‐(benzylideneamino)‐4H‐1,2,4‐triazole‐3,5‐diyl) dimethanol (BATD), and (4‐(4‐(dimethylamino) benzylideneamino))‐4H‐1,2,4‐triazole‐3,5‐diyl) dimethanol (DBATD) on copper in 1 N sulfuric acid was investigated by potenti